Literature DB >> 26179719

Complications of percutaneous thrombin injection in patients with postcatheterization femoral pseudoaneurysm.

Jacek Kurzawski1, Marcin Sadowski1, Agnieszka Janion-Sadowska1.   

Abstract

PURPOSE: To study the complications of ultrasound-guided thrombin injection of pseudo-aneurysms occurring after interventional cardiovascular procedures.
METHOD: We prospectively studied 353 patients who developed post-catheterization femoral artery pseudo-aneurysms and were treated with ultrasound-guided thrombin injection.
RESULTS: Arterial micro-embolization occurred in 53 patients (15%) and pulmonary embolism in 1 patient (0.3%). None of the patients developed significant peripheral arterial embolism. The length of the communicating channel between the arterial lumen and the pseudo-aneurysm was inversely correlated with the risk of embolization (p < 0.0001). A 4.6 mm increase in channel length decreased the odds of embolization by 14%, and patients with a channel less than 2 mm long were at greater risk. Repeated thrombin injection also increased the risk of embolization (p = 0.02).
CONCLUSION: Thrombin injection for the treatment of post-catheterization femoral pseudo-aneurysm is feasible and safe, but it must be performed with caution, especially when the sac is directly communicating with the artery, or when success cannot be achieved with a single injection.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  complication; femoral artery; pseudoaneurysm; thrombin injection

Mesh:

Substances:

Year:  2015        PMID: 26179719     DOI: 10.1002/jcu.22274

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  8 in total

1.  A novel minimally invasive method of successful tissue glue injection in patients with iatrogenic pseudoaneurysm.

Authors:  Jacek Kurzawski; Agnieszka Janion-Sadowska; Marcin Sadowski
Journal:  Br J Radiol       Date:  2018-03-02       Impact factor: 3.039

2.  Factors associated with pseudoaneurysm development and necessity for reintervention: a single centre study.

Authors:  Jonathan Delf; Sanjeev Ramachandran; Syed Mustafa; Abdullah Saeed; Neghal Kandiyil
Journal:  Br J Radiol       Date:  2019-05-15       Impact factor: 3.039

3.  Late to early velocity index as a predictor of iatrogenic femoral artery pseudoaneurysm recurrence in patients treated with ultrasound-guided thrombin injection.

Authors:  Jacek Kurzawski; Agnieszka Janion-Sadowska; Łukasz Zandecki; Marianna Janion; Marcin Sadowski
Journal:  Arch Med Sci       Date:  2019-05-21       Impact factor: 3.318

4.  Ultrasound-Guided Fibrin Glue Injection for Treatment of Iatrogenic Femoral Pseudoaneurysms.

Authors:  Maria Gummerer; Moritz Kummann; Alexandra Gratl; Daniela Haller; Andreas Frech; Josef Klocker; Gustav Fraedrich; Hannes Gruber
Journal:  Vasc Endovascular Surg       Date:  2020-06-19       Impact factor: 1.089

5.  Percutaneous Thrombin Injection Based on Computational Fluid Dynamics of Femoral Artery Pseudoaneurysms.

Authors:  Hyoung-Ho Kim; Kyung-Wuk Kim; Changje Lee; Young Ho Choi; Min Uk Kim; Yasutaka Baba
Journal:  Korean J Radiol       Date:  2021-07-26       Impact factor: 3.500

6.  Peripartum hemorrhage: Two cases of ruptured ovarian artery aneurysms with additional multifocal intact aneurysms.

Authors:  Timothy L Arleo; Gail L Peters; Nima Kokabi; Bill S Majdalany
Journal:  J Clin Imaging Sci       Date:  2022-03-16

7.  Percutaneous ultrasound-guided balloon-assisted embolization of iatrogenic femoral artery pseudoaneurysms with Glubran®2 cyanoacrylate glue: safety, efficacy and outcomes.

Authors:  Loïc Griviau; Olivier Chevallier; Clément Marcelin; Motoki Nakai; Lorenzo Pescatori; Christophe Galland; Marco Midulla; Nicolas Falvo; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2018-09

8.  Successful Treatment of a Superficial Femoral Artery Pseudoaneurysm with Balloon Tamponade.

Authors:  Hugo Laparra-Escareno; Cesar Cuen-Ojeda; Ramon García-Alva; Gabriel Lopez-Pena; Javier E Anaya-Ayala; Carlos A Hinojosa
Journal:  Vasc Specialist Int       Date:  2019-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.